DNA and RNA Vaccines: Current Status, Quality Requirements and Specific Aspects of Preclinical Studies
This review focuses on DNA and RNA vaccines whose potential use was first considered at the end of the 20th century. However, not a single bacterial plasmid-based or mRNA vaccine has been used since that time in public healthcare for the prevention of infectious diseases. Nevertheless, vaccines cont...
Saved in:
| Main Authors: | A. A. Goryaev, M. V. Savkina, Yu. I. Obukhov, V. A. Merkulov, Yu. V. Olefir |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2019-06-01
|
| Series: | Биопрепараты: Профилактика, диагностика, лечение |
| Subjects: | |
| Online Access: | https://www.biopreparations.ru/jour/article/view/218 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systemic mRNA aggregates elicit immunologic reprogramming that unlocks anti-cancer immunity
by: Hector R. Mendez-Gomez, et al.
Published: (2025-12-01) -
COVID-19 Vaccination Enhances the Immunogenicity of Seasonal Influenza Vaccination in the Elderly
by: Engin Berber, et al.
Published: (2025-05-01) -
Immunogenicity and safety of self-amplifying mRNA COVID-19 vaccine (ARCT-2303), with or without co-administration of seasonal inactivated influenza vaccine in adults: a phase 3, randomised, controlled, observer-blind, multicentre studyResearch in context
by: Michelle L. Giles, et al.
Published: (2025-09-01) -
mRNA vaccines and SiRNAs targeting cancer immunotherapy: challenges and opportunities
by: Zhen Lv, et al.
Published: (2025-07-01) -
Nanoparticle-Based mRNA Vaccine Induces Protective Neutralizing Antibodies Against Infectious Bronchitis Virus in In-Vivo Infection
by: Aseno Sakhrie, et al.
Published: (2025-05-01)